GraniteShares YieldBOOST CRCL ETF (CRY)

Form 4 - Statement of changes in beneficial ownership of securities

CryoLife Sends Letter to Medafor, Inc. Shareholders

ATLANTA, Feb. 23 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Increases Stake in Medafor, Inc. to Approximately 11 Percent

ATLANTA, Feb. 2 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Provides Initial 2010 Financial Guidance

Company expects record revenues and operating profits in 2010 ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable...

CryoLife to Present at Upcoming Investor Conferences in New York

ATLANTA, Nov. 11 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Reports Record Quarterly Revenues of $28.2 Million

Company posts fully diluted earnings per share of $0.07 for third quarter of 2009; Revenues increased 5 percent for third quarter of 2009 compared...

CryoLife to Present at UBS Global Life Sciences Conference

ATLANTA, Sept. 14 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Announces First Clinical Use of BioFoam(R)

Newly CE Marked Product Used to Stop Bleeding During Liver Resection ATLANTA and LONDON, Sept. 10 /PRNewswire-FirstCall/ -- CryoLife, Inc...

CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material

ATLANTA, Aug. 18 /PRNewswire-FirstCall/ -- CryoLife, Inc., (NYSE:CRY) an implantable biological medical device and cardiovascular tissue...

CryoLife Reports Record Quarterly Revenues of $28.2 Million

Company posts fully diluted earnings per share of $0.09 for second quarter of 2009; Revenues increased 6 percent sequentially for second quarter...